Pediatric Immunization & Wellness
Key Takeaways
- The UAE MOHAP immunization schedule dictates BCG and Hepatitis B at birth, followed by Hexavalent and PCV13 vaccines starting at 2 months.
- Live attenuated vaccines (MMR, Varicella, Rotavirus) are absolutely contraindicated in severely immunocompromised patients and during pregnancy.
- Mild illness, low-grade fever, recent antibiotic use, and breastfeeding are not contraindications to vaccination.
- For infants and toddlers (<3 years), the anterolateral thigh (vastus lateralis) is the preferred site for intramuscular injections.
- Car seat safety requires rear-facing seats in the back until at least age 2, and all children under 13 should sit in the back seat.
Pediatric Immunization and Wellness
Immunization is a core component of pediatric preventative health and is heavily tested on the DHA exam. Registered nurses must understand the immunization schedules, vaccine types, absolute contraindications, precautions, and safe administration techniques. Additionally, nurses play a critical role in wellness promotion, including nutritional guidance, dental hygiene, and injury prevention, which are key aspects of pediatric care.
UAE National Immunization Programme (NIP) & WHO Guidelines
The United Arab Emirates Ministry of Health and Prevention (MOHAP) mandates a comprehensive immunization schedule for children from birth through school age. This schedule aligns with WHO recommendations and protects against major communicable diseases.
| Age | Vaccine(s) Administered | Disease Coverage |
|---|---|---|
| Birth | BCG (Bacillus Calmette-Guérin)<br>Hepatitis B (HepB - 1st dose) | Tuberculosis<br>Hepatitis B |
| 2 Months | Hexavalent (DTaP-HepB-IPV-Hib - 1st dose)<br>PCV13 (Pneumococcal - 1st dose)<br>Rotavirus (1st dose - oral) | Diphtheria, Tetanus, Pertussis, HepB, Polio, Hib<br>Pneumococcal diseases<br>Rotavirus gastroenteritis |
| 4 Months | Hexavalent (DTaP-HepB-IPV-Hib - 2nd dose)<br>PCV13 (2nd dose)<br>Rotavirus (2nd dose - oral) | Diphtheria, Tetanus, Pertussis, HepB, Polio, Hib<br>Pneumococcal diseases<br>Rotavirus gastroenteritis |
| 6 Months | Hexavalent (DTaP-HepB-IPV-Hib - 3rd dose)<br>PCV13 (3rd dose)<br>Rotavirus (3rd dose - if using 3-dose brand) | Diphtheria, Tetanus, Pertussis, HepB, Polio, Hib<br>Pneumococcal diseases<br>Rotavirus gastroenteritis |
| 12 Months | MMR (1st dose)<br>Varicella (1st dose)<br>PCV13 (4th dose / Booster)<br>MCV4 (Meningococcal - 1st dose) | Measles, Mumps, Rubella<br>Chickenpox<br>Pneumococcal diseases<br>Meningococcal meningitis |
| 18 Months | Pentavalent booster (DTaP-IPV-Hib)<br>MMR (2nd dose)<br>Varicella (2nd dose)<br>Hepatitis A (HepA - 1st dose) | Diphtheria, Tetanus, Pertussis, Polio, Hib<br>Measles, Mumps, Rubella<br>Chickenpox<br>Hepatitis A |
| 24 Months | Hepatitis A (HepA - 2nd dose) | Hepatitis A |
| 5–6 Years | DTaP booster<br>IPV booster<br>MMR booster<br>Varicella booster | Diphtheria, Tetanus, Pertussis<br>Polio<br>Measles, Mumps, Rubella<br>Chickenpox |
| 11–12 Years | HPV (Human Papillomavirus - 2 doses) | Cervical, vulvar, vaginal, and anal cancers |
| 15–18 Years | Tdap booster | Tetanus, Diphtheria, Pertussis |
Live Attenuated vs. Inactivated Vaccines
Understanding the classification of vaccines is crucial because live vaccines carry specific clinical precautions.
- Live Attenuated Vaccines: Contain a weakened form of the wild virus or bacteria. Examples include MMR, Varicella, Rotavirus, BCG, and nasal spray Influenza. These vaccines produce a strong, long-lasting immune response but are contraindicated in immunocompromised individuals.
- Inactivated/Recombinant/Conjugate/Toxoid Vaccines: Contain killed pathogens or specific antigen parts. Examples include DTaP, Hepatitis B, IPV, Hib, PCV13, and MCV4. These are safe for immunocompromised patients, though they may require booster doses to maintain immunity.
Contraindications, Precautions, and Common Misconceptions
A major clinical responsibility of the nurse is screening children for contraindications prior to administering any vaccine.
Absolute Contraindications
- Anaphylaxis: A history of a severe, life-threatening allergic reaction after a previous dose of the vaccine or to any vaccine component (e.g., neomycin or gelatin in MMR/Varicella, yeast in Hepatitis B).
- Severe Immunosuid: Immunosuppression: Live vaccines (MMR, Varicella) must never be administered to children who are severely immunocompromised (e.g., active chemotherapy, congenital immunodeficiency, HIV with CD4+ T-lymphocyte counts below age-specific thresholds, or receiving high-dose systemic corticosteroids for >14 days).
- Pregnancy: Live vaccines are contraindicated due to the theoretical risk of transmission to the fetus (relevant to female adolescents).
- Encephalopathy: Any occurrence of encephalopathy within 7 days of receiving a pertussis-containing vaccine (DTaP) that is not attributable to another cause is an absolute contraindication to the pertussis component.
Precautions (Deferral Recommended)
- Moderate or Severe Acute Illness: Children with moderate-to-severe acute illness, with or without a fever (e.g., pneumonia, severe gastroenteritis), should have their vaccinations deferred until they recover to avoid masking changes in their clinical condition.
Common Misconceptions (NOT Contraindications)
The following are safe scenarios for vaccination (frequently used as exam distractors):
- Mild acute illness (e.g., low-grade fever <38.5°C, mild cold, otitis media, mild diarrhea).
- Current antibiotic therapy.
- Recent exposure to an infectious disease.
- Breastfeeding (both mother and infant can receive recommended vaccines).
- Family history of adverse reactions to vaccines or seizures.
- Local reaction (redness, swelling, mild soreness) to a previous dose.
Safe Vaccine Administration Guidelines
Nurses must follow evidence-based protocols to minimize injection pain and ensure safe delivery.
Site and Route Selection
- Intramuscular (IM) Injections:
- Vastus Lateralis (Anterolateral Thigh): The preferred site for infants and toddlers (<3 years) due to its large muscle mass.
- Deltoid Muscle: Used for older children (≥3 years) and adolescents who have sufficient muscle mass.
- Needle Size: Typically 22 to 25 gauge. The needle length is 1 inch (25 mm) for infants and toddlers in the thigh, and 5/8 to 1 inch for the deltoid in older children, injected at a 90-degree angle.
- Subcutaneous (SC) Injections:
- Administered in the fatty tissue over the anterolateral thigh (infants) or outer triceps (older children).
- Used for live vaccines (e.g., MMR, Varicella) at a 45-degree angle with a 5/8 inch (16 mm), 23 to 25 gauge needle.
Pediatric Pain Mitigation
- Infants (<6 months): Administer 24% oral sucrose solution 2 minutes before the injection, encourage breastfeeding during the procedure, or offer a pacifier.
- Comfort Holds: Have the caregiver hold the child in a comforting position (e.g., chest-to-chest) rather than restraining them flat on the examination table.
- Distraction: Use bubbles, toys, or deep breathing for toddlers and preschoolers.
- Medication Safety: Never administer aspirin to children to treat post-vaccine fever or pain due to the risk of Reye's syndrome (a rare but fatal condition causing encephalopathy and liver damage). Recommend paracetamol (acetaminophen) or ibuprofen instead.
Health Promotion and Preventive Screening
Pediatric wellness visits incorporate ongoing health promotion:
Nutritional Guidance & Screenings
- Iron Supplementation: Exclusively breastfed infants should receive 1 mg/kg/day of oral iron starting at 4 months until iron-rich solid foods (such as iron-fortified cereals) are introduced, to prevent iron-deficiency anemia.
- Vitamin D: All breastfed and partially breastfed infants should receive 400 IU of oral vitamin D daily beginning in the first few days of life.
Dental Hygiene
- The first dental visit should occur by 1 year of age or within 6 months of the eruption of the first primary tooth.
- To prevent dental fluorosis while protecting teeth, caregivers should use a smear (rice-sized amount) of fluoride toothpaste for children under 3 years, and a pea-sized amount for children aged 3 to 6 years.
Childhood Injury Prevention
Injury prevention strategies must align with the child's developmental age:
- Infants (0 to 1 year):
- Sudden Infant Death Syndrome (SIDS) Prevention: Infants must sleep on their back on a firm mattress in a crib free of loose blankets, pillows, bumper pads, or stuffed animals. Co-sleeping is strongly discouraged.
- Choking Prevention: Avoid small toys, buttons, coins, and foods like whole grapes, nuts, or hot dogs unless cut into very small pieces.
- Toddlers and Preschoolers (1 to 5 years):
- Poison Prevention: Store all medications, household cleaners, and chemicals in locked cabinets out of reach. Keep the poison control number accessible.
- Drowning Prevention: Ensure constant supervision around water. Gate off swimming pools with self-closing, self-latching fences at least 1.2 meters high.
- Car Seat Safety Guidelines:
- Rear-Facing Car Seat: Keep the child in a rear-facing seat in the back seat of the vehicle until at least 2 years of age or until they reach the maximum weight/height limits of the seat.
- Forward-Facing Car Seat: Once they outgrow the rear-facing seat, use a forward-facing seat with a harness in the back seat.
- Booster Seat: Transition to a belt-positioning booster seat when they outgrow the forward-facing seat, typically until they reach 4 feet 9 inches (145 cm) in height and are 8 to 12 years of age.
- Back Seat Safety: All children under 13 years must ride in the back seat of the vehicle to avoid airbag-related injuries.
A nurse is preparing to administer routine vaccinations to a 12-month-old child. The child's mother states that the child is currently receiving high-dose systemic corticosteroid therapy for an autoimmune condition. Which of the following vaccines should the nurse withhold?
The nurse is providing discharge education to the parents of a newborn regarding car seat safety. Which instruction should the nurse include to ensure compliance with evidence-based safety standards?
A nurse is preparing to administer the DTaP-HepB-IPV-Hib (Hexavalent) vaccine to a healthy 4-month-old infant. Which of the following administration techniques is correct?